Chemoresponse Assay Could Lower Treatment Costs in Ovarian Cancer - ChemoFx Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, May 25, 2010

Chemoresponse Assay Could Lower Treatment Costs in Ovarian Cancer - ChemoFx



 "...In the study, the authors assumed, for the sake of analysis, that the "outcomes are likely no worse when chemoresponse testing is performed than when an empiric choice of regimen is made."
However, if, in currently ongoing studies, the assay helps clinicians choose more effective therapies and thus improve survival, it would be "very attractive from a health economics perspective," say the authors, because the current study has already shown it to be cost effective."
 
The study was funded by Precision Therapeutics.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.